SOHO 2026 Archives - Page 4 of 7 - SOHO Insider

Skip to content

Phase 1b trial reports promising outcomes with olverembatinib plus blinatumomab in relapsed or refractory CML or ALL
SOHO 2026 posters not to miss: MPN edition with Dr. Gabriela Hobbs
Young investigators define the SOHO difference
Dr. Jerald Radich highlights meaningful posters in CML at SOHO 2026
The state of SOHO: a year of growth and opportunity

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

The SOHO Ambassador Program connects a global community

Cellular Therapy

The SOHO Ambassador Program connects a global community

Leukemia

The SOHO Ambassador Program connects a global community

Lymphoma

The SOHO Ambassador Program connects a global community

Multiple Myeloma

The SOHO Ambassador Program connects a global community

Myelodysplastic Syndromes

The SOHO Ambassador Program connects a global community

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

September 21, 2026

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2026

MDS News MPN News Lymphoma News Myeloma News ALL News AML News

SOHO 2026

News and highlights from the 14th Annual Meeting of SOHO in Houston.

SOHO 2026 Trending now Meetings / Conferences News

The SOHO Ambassador Program connects a global community

by Phillip Scheinberg, MD, PhD
September 9, 2026
0 Comments

SOHO 2026 Meetings / Conferences

How do we keep blood cancer research moving forward?

by Leah Sherwood
September 8, 2026
0 Comments

MDS News SOHO 2026 Trending now Meetings / Conferences News

Alan List, MD, to receive SOHO Freireich Pioneer Award, deliver Wednesday plenary on lower-risk MDS

by Rami Komrokji, MD
September 8, 2026
0 Comments

Multiple Myeloma News SOHO 2026 Trending now News

CELMoDs in multiple myeloma: a decade of progress

by Ajay Nooka, MD, MPH
September 8, 2026
0 Comments

SOHO 2026 Leukemia Acute Myeloid Leukemia News

Menin inhibitors are making an impact in acute leukemia

by Leah Sherwood
September 8, 2026
0 Comments

Dr. John DiPersio

SOHO 2026 News

Advancing care means protecting the environment that makes discovery possible

by SOHO Insider Editors
September 8, 2026
0 Comments

Lymphoma News SOHO 2026 News

SOHO 2026: Pharma trials in lymphoma with Drs. Nastoupil, Shah

by SOHO Insider Editors
September 7, 2026
0 Comments

Acute Lymphoblastic Leukemia News SOHO 2026 Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences News

Session sparks debate on whether chemotherapy is needed in ALL care

by Elias Jabbour, MD
September 7, 2026
0 Comments

Multiple Myeloma News SOHO 2026

Can’t-miss presentation: Meet-the-Professor session on immunotherapy trials with Doris K. Hansen

by Leah Sherwood
September 7, 2026
0 Comments

Acute Myeloid Leukemia SOHO 2026 News

Do the data support a departure from intensive treatment in younger patients with AML?

by Amir Fathi, MD and Christian Recher, MD, PhD
September 7, 2026
0 Comments

1
2
3
4
5
6
7

Top Categories

Cellular Therapy

82

Leukemia

134

Lymphoma

141

Multiple Myeloma

120

Myelodysplastic Syndromes

49

Myeloproliferative Neoplasms

36

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Do the data support a departure from intensive treatment in younger patients with AML?

Cellular Therapy

Do the data support a departure from intensive treatment in younger patients with AML?

Leukemia

Do the data support a departure from intensive treatment in younger patients with AML?

Lymphoma

Do the data support a departure from intensive treatment in younger patients with AML?

Multiple Myeloma

Do the data support a departure from intensive treatment in younger patients with AML?

Myelodysplastic Syndromes

Do the data support a departure from intensive treatment in younger patients with AML?

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Phase 1b trial reports promising outcomes with olverembatinib plus blinatumomab in relapsed or refractory CML or ALL

SOHO 2026 posters not to miss: MPN edition with Dr. Gabriela Hobbs

POWERFUL-400x400

Young investigators define the SOHO difference

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.